The protective effect of glycyrrhizin on anti-Fas antibody-induced hepatitis in mice
- 27 January 2000
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 387 (2) , 229-232
- https://doi.org/10.1016/s0014-2999(99)00807-9
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Chronic Hepatitis in Interferon-γ Transgenic Mice Is Associated With Elevated CPP32-Like Activity and Interleukin-1β-Converting Enzyme Activity SuppressionThe Japanese Journal of Pharmacology, 1999
- Therapy of hepatitis C: OverviewHepatology, 1997
- The long term efficacy of glycyrrhizin in chronic hepatitis C patientsCancer, 1997
- Apoptosis by Death FactorCell, 1997
- Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death.The Journal of Experimental Medicine, 1996
- TNF-α Gene Expression in the Liver of the IFN-γ Transgenic Mouse with Chronic Active HepatitisBiochemical and Biophysical Research Communications, 1996
- Role of Fas Ligand in Apoptosis Induced by Hepatitis C Virus InfectionBiochemical and Biophysical Research Communications, 1994
- Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis CHepatology, 1994
- Lethal effect of the anti-Fas antibody in miceNature, 1993
- Possible mechanism of steroid action of the plant herb extracts glycyrrhizin, glycyrrhetinic acid, and paeoniflorin: Inhibition by plant herb extracts of steroid protein binding in the rabbitAmerican Journal of Obstetrics and Gynecology, 1986